Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

Abroad (travel likely)RecruitingPHASE4

Conditions

Aortic Stenosis · TAVI(Transcatheter Aortic Valve Implantation) · Aspirin · DAPT(Dual Antiplatelet Therapy) · SAPT(Single Antiplatelet Therapy)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Keio University Hospital, Shinjuku, Tokyo, Japan

    Contact: Study coordinator (Kentaro Hayashida) · khayashida.z6@keio.jp · 03-5843-6702
    Contact: Study coordinator (Masanori Yamamoto)
    Contact: Study coordinator (Tetsuro Shimura)
    Contact: Study coordinator (Takahiro Tokuda)
    Contact: Study coordinator (Masahiko Noguchi)
    Contact: Study coordinator (Hiroshi Ueno)
    Contact: Study coordinator (Hiroto Suzuyama)
    Contact: Study coordinator (Masahiko Asami)
    Contact: Study coordinator (Shinichi Shirai)
    Contact: Study coordinator (Yusuke Watanabe)
    Contact: Study coordinator (Kouhei Yamaguchi)
    Contact: Study coordinator (Norio Tada)
    Contact: Study coordinator (Futoshi Yamanaka)
    Contact: Study coordinator (Yohei Ohno)
    Contact: Study coordinator (Masaki Izumo)
    Contact: Study coordinator (Kazumasa Yamasaki)
    Contact: Study coordinator (Hidetaka Nishina)
    Contact: Study coordinator (Yasushi Fuku)
    Contact: Study coordinator (Gaku Nakazawa)
    Contact: Study coordinator (Fumiaki Yashima)
Study leads
  • Yosuke Sawa

    Study Director

    EPS Corporation